Skip to main content
. 2023 Apr 10;28(9):e823–e834. doi: 10.1093/oncolo/oyad059
Patient Characteristics [Phase II Part]
Number of patients, male 15
Number of patients, female 3
Stage Stage IV (100%)
Age: median (range) 67 (56-84)
Number of prior systemic therapies: median (range) 1
Performance status: ECOG 0: 7
1: 11
2: 0
3: 0
4: 0
Cancer types or histologic subtypes Stomach cancer (adenocarcinoma): 18
[PTEN (−) by IHC, n = 18; PIK3CB mutation, n = 1]